Skip to main content
Clinical Trials/NCT00608075
NCT00608075UnknownPhase 4

Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

University of Cincinnati1 site in 1 country260 target enrollmentStarted: April 2007Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
260
Locations
1
Primary Endpoint
The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.

Study Overview

Brief Summary

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium, an FDA-approved treatment for bipolar mania, in order to better understand who benefits from treatment and why they respond to medications. Studying this may help improve treatment and outcome in patients with bipolar disorder.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
15 Years to 55 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Other

Manic Patients

Intervention: Lithium (Drug)

2

Other

Depressed Patients

Intervention: Lithium (Drug)

Outcomes

Primary Outcomes

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving lithium.

Time Frame: 8 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Caleb M. Adler

Associate Professor

University of Cincinnati

Study Sites (1)

Loading locations...

Similar Trials